FDA Inspection 1096830 — Eurofins Biopharma Product Testing Sweden AB
The FDA completed an inspection of Eurofins Biopharma Product Testing Sweden AB on Jun 27, 2019 in Uppsala. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 27, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Uppsala (Sweden)